Alx Oncology's stock price closed at $5.04. It is down -22.82% in the last 3 months and down -65.29% in the last 12 months. Alx Oncology saw 2 positive EPS revisions and 0 negative EPS revisions in ...

ALX Oncology exceeded EPS expectations with a 10.53% surprise. The stock price surged 11.23% post-earnings. Strong financial position due to a successful financing round. Promising clinical trial ...

Alexander's (ALX) came out with quarterly funds from operations (FFO) of $4.06 per share, beating the Zacks Consensus Estimate of $3.57 per share. This compares to FFO of $4.98 per share a year ago.

Alexanders press release (NYSE:ALX): Q1 FFO of $4.25 beats by $0.03. Revenue of $49.21M (-12.4% Y/Y) misses by $0.99M. Recommended For You ...